Leonteq Securities AG

Broker-Dealer

Position in MRNA — Moderna, Inc.

CIK 1535950 ZURICH, V8

Back to MRNA Full portfolio

Position in MRNA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$15,360,650

+$5,461,860 QoQ

Shares Held

302,375

-9.9% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

22 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$863,600

PutShares

17,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Leonteq Securities AG holds $25,859,639 across 58 Biotechnology names. MRNA ranks #1 (59.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	302,375	$15,360,650
2	BNTX	BioNTech SE	26,784	$2,380,561
3	VRTX	Vertex Pharmaceuticals Inc / Ma	4,260	$1,902,260
4	REGN	Regeneron Pharmaceuticals, Inc.	1,212	$936,439
5	VKTX	Viking Therapeutics, Inc.	22,812	$742,302
6	IOVA	Iovance Biotherapeutics, Inc.	160,000	$561,600
7	AXSM	Axsome Therapeutics, Inc.	2,644	$446,888
8	BEAM	Beam Therapeutics Inc.	12,367	$294,705

All Filings in MRNA

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,360,650	302,375	+1678.7%	Shares	Sole	2026-04-27
2026-03-31	$863,600	17,000	-94.9%	Put	Sole	2026-04-27
2025-12-31	$9,898,790	335,666	+1874.5%	Shares	Sole	2026-02-06
2025-12-31	$501,330	17,000	-96.9%	Put	Sole	2026-02-06
2025-09-30	$13,951,609	540,132	+1.3%	Shares	Sole	2026-02-17
2025-06-30	$14,714,602	533,331	+22.2%	Shares	Sole	2026-02-17
2025-03-31	$12,376,787	436,571	+7176.2%	Shares	Sole	2026-02-23
2024-12-31	$249,480	6,000	-96.8%	Call	Sole	2026-02-23
2024-12-31	$7,706,769	185,348	+2989.1%	Shares	Sole	2026-02-23
2024-09-30	$400,980	6,000	-95.4%	Call	Sole	2026-03-04
2024-09-30	$8,707,614	130,295	+1867.9%	Shares	Sole	2026-03-04
2024-06-30	$786,243	6,621	+10.3%	Shares	Sole	2026-03-04
2024-06-30	$712,500	6,000	-88.1%	Call	Sole	2026-03-04
2024-03-31	$5,384,583	50,531	+168.8%	Shares	Sole	2026-03-11
2024-03-31	$2,003,328	18,800	-62.9%	Call	Sole	2026-03-11
2023-12-31	$5,034,755	50,626	-61.3%	Shares	Sole	2026-03-11
2023-12-31	$12,998,115	130,700	+52.2%	Call	Sole	2026-03-11
2023-09-30	$8,872,611	85,900	-2.4%	Call	Sole	2026-03-11
2023-09-30	$9,088,073	87,986	+145.1%	Shares	Sole	2026-03-11
2023-06-30	$4,361,850	35,900	-68.5%	Call	Sole	2026-03-11
2023-06-30	$13,862,907	114,098	+358.0%	Shares	Sole	2026-03-11
2023-03-31	$3,826,292	24,914	-79.0%	Shares	Sole	2026-03-11
2023-03-31	$18,199,230	118,500	+63.4%	Call	Sole	2026-03-11
2022-12-31	$13,022,450	72,500	-30.6%	Call	Sole	2026-03-26
2022-12-31	$18,766,877	104,481	-69.1%	Shares	Sole	2026-03-26
2022-09-30	$39,967,081	337,988	+366.2%	Shares	Sole	2026-03-26
2022-09-30	$8,573,125	72,500	-76.0%	Call	Sole	2026-03-26
2022-06-30	$43,141,699	302,007	+316.6%	Shares	Sole	2026-03-26
2022-06-30	$10,356,625	72,500	-27.5%	Call	Sole	2026-03-26
2022-03-31	$17,226,000	100,000	-50.9%	Call	Sole	2026-03-26
2022-03-31	$35,079,026	203,640	+53.2%	Shares	Sole	2026-03-26
2021-12-31	$33,765,117	132,944	+328.9%	Shares	Sole	2026-03-26
2021-09-30	$11,930,275	30,999	+34.1%	Shares	Sole	2026-03-26
2021-06-30	$5,431,797	23,116	+10.9%	Shares	Sole	2026-03-26
2021-03-31	$2,728,736	20,838	+58.6%	Shares	Sole	2026-03-26
2020-12-31	$1,372,735	13,140	—	Shares	Sole	2026-03-26
No filing history on record for this holder in this stock.